Baxter (NYSE:BAX) announced today that it has issued an urgent safety communication regarding upstream occlusion alarms for certain infusion pumps.
Deerfield, Illinois–based Baxter warned that incorrect administration set setup and/or the incomplete resolution of upstream occlusion alarms may result in reduced delivery or non-delivery of medication. The problem might occur without the users receiving alerts via pump alarm in some cases. The issue involves all Spectrum V8 and Spectrum IQ infusion pumps.
Baxter received 51 reports of serious injury and three reports of patient death over five years that may have resulted from incorrect administration set setup or incomplete resolution of upstream occlusion alarms.
Get the full story at our sister site, Drug Delivery Business News.